This study looked at whether a clinician training program for enhancing patient-counselor communication about sexual risk behavior in those with substance use disorder was effective.
All articles by Emily Pond
Investigators searched the PubMed, PsycINFO, and Embase databases from inception through February 2021 for studies describing the cognitive performance of patients with bipolar disorder with and without comorbid substance abuse disorder.
To better explore the effects of medical marijuana, investigators conducted a pragmatic, single-site, single-blind randomized controlled trial in the Greater Boston area between 2017 and 2020.
Researchers conducted subgroup analyses using data from the 2019 Global Burden of Disease study to assess the burden in the global distribution of hip osteoarthritis.
Study data published in Neuropsychiatric Disease and Treatment outline the primary factors affecting attrition in buprenorphine treatment for opioid use disorder.
The review authors sought to elucidate the neurological harms of methamphetamine, which are well-documented but poorly understood.
While prior research indicates that cannabis use may increase the severity of certain psychiatric symptoms, its impact on suicidality is unknown. To inform this gap, investigators extracted data from the National Surveys on Drug Use and Health for the years 2008 through 2019.
Study data published in PLoS One suggest that gender minority (GM) adolescents may engage in substance use more frequently than their peers.
With overdose deaths spiking during the early months of the COVID-19 pandemic, data was not disaggregated by month, race/ethnicity, or other social attributes. The study investigators utilized data from emergency medical services in racial/ethnic, social, and geographic trends in overdose-related cardiac arrests.
This study asks the question, do Black and Latinx transgender youth experience greater mental health symptoms than their White transgender and Black and Latinx cisgender peers?